RVP

Drug Catalog - Product Detail

PHENAZOPYRIDINE HCL TAB 100 MG 100 CT

NDC Mfr Size Str Form
69367-0162-04 WESTMINSTER PHARMACEUTICALS 100 100MG TABLET
Product Image
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION Phenazopyridine Hydrochloride is a reddish-brown, odorless, slightly bitter, crystalline powder. It has a specific local analgesic effect in the urinary tract, promptly relieving burning and pain. Following is the structural formula: C11H11N5 ∙ HCl M.W. 249.70 Phenazopyridine HCl oral tablets contain the following inactive ingredients: Crospovidone, Macrogol, Polysorbate 80, Polyvinyl Alcohol, Talc. Chemical Structure
How Supplied
HOW SUPPLIED Dispense contents with a child-resistant closure (as required) and in a tight container as defined in the USP. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature]. NDC 69367-162-04 100 mg, 100 count - Appearance: Reddish-brown, round, film coated tablets debossed "812" on one side and plain on the other. 9 Count NDC 68788-7243-09 10 Count NDC 68788-7243-01 15 Count NDC 68788-7243-05 20 Count NDC 68788-7243-02 30 Count NDC 68788-7243-03 To report an adverse reaction, please contact Westminster Pharmaceuticals, LLC at 1-844-221-7294 KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.
Indications & Usage
INDICATIONS AND USAGE Phenazopyridine HCL is indicated for the symptomatic relief of pain, burning, urgency frequency, and other discomforts arising from irritation of the mucosa of the lower urinary tract caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters. The use of Phenazopyridine for relief of symptoms should not delay definitive diagnosis and treatment of causative conditions. The drug should be used for symptomatic relief of pain and not as a substitute for specific surgery or antimicrobial therapy. Phenazopyridine is compatible with antimicrobial therapy and can help relieve pain and discomfort during the interval before antimicrobial therapy controls the infection. Treatment of a urinary tract infection with Phenazopyridine should not exceed 2 days. There is no evidence that the combined administration of Phenazopyridine and an antimicrobial provides greater benefit than administration of the antimicrobial alone after 2 days. (See Dosage and Administration .)
Dosage and Administration
DOSAGE AND ADMINISTRATION 100 mg Tablets: Average adult dosage is two tablets 3 times a day after meals. When used concomitantly with an antibacterial agent for the treatment of a urinary tract infection, the administration of Phenazopyridine Hydrochloride should not exceed 2 days.